Hartoun Hartounian - 01 Jan 2025 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role: EVP, Chief Operating Officer
Signature: /s/ Hartoun Hartounian
Issuer symbol: BCLI
Transactions as of: 01 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Jan 2025, 17:31:34 UTC
Previous filing: 25 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCLI	Common Stock	Award	$0	+50,000	+2500%	$0.000000	52,000	01 Jan 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
F2	Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Content

Represents shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.